Recursion Pharmaceuticals, Inc. (RXRX) vs DENTSPLY SIRONA Inc. (XRAY)
A side-by-side comparison of Recursion Pharmaceuticals, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
RXRX
Recursion Pharmaceuticals, Inc.
$4.08HealthcareDelayed quote: Oct 2, 2026, 3:40 PM EDT
XRAY
DENTSPLY SIRONA Inc.
$8.62HealthcareDelayed quote: Oct 2, 2026, 3:40 PM EDT
Total return — RXRX vs XRAY
growth of $100 · dividends reinvested · last 5yRXRX -77.4% (-25.7%/yr)XRAY -84.8% (-31.4%/yr)RXRX compounded faster over this window
RXRX XRAY
RXRX vs XRAY: by the numbers
- •RXRX is the larger company ($2.14B vs $1.73B market cap).
- •Both run net losses; XRAY's is the smaller (-14.99% vs -945.92% net margin).
- •RXRX grew revenue faster over the past five years (45.50% vs 1.96% CAGR).
- •XRAY pays a dividend (3.66% yield), while RXRX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | RXRX | XRAY |
|---|---|---|
| Forward P/E | N/A | 5.65 |
| P/S ratio | 39.05 | 0.47 |
| P/B ratio | 2.34 | 1.28 |
| EV / EBITDA | N/A | 4.45 |
| FCF yield | N/A | 8.28% |
Profitability
| Metric | RXRX | XRAY |
|---|---|---|
| Gross margin | -61.96% | 49.52% |
| Operating margin | -867.87% | 11.69% |
| Net margin | -945.92% | -14.99% |
| ROE | -56.71% | -40.41% |
| ROIC | -49.78% | 10.03% |
Dividends
| Metric | RXRX | XRAY |
|---|---|---|
| Dividend yield | N/A | 3.66% |
Growth (annualized)
| Metric | RXRX | XRAY |
|---|---|---|
| Revenue CAGR (5Y) | 45.50% | 1.96% |
| FCF CAGR (5Y) | N/A | -25.74% |
| Total return CAGR (5Y) | -28.56% | -30.33% |
Frequently asked
- Which has grown faster, RXRX or XRAY?
- Over the past five years, RXRX grew revenue faster — RXRX at a 45.50% CAGR versus XRAY at 1.96%.
- Does RXRX or XRAY pay a bigger dividend?
- XRAY pays a dividend (3.66% yield), while RXRX has no payments in the available dividend history.
- How have RXRX and XRAY total returns compared?
- Over the past 5 years, RXRX delivered -28.56% and XRAY delivered -30.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DENTSPLY SIRONA dividend yieldRecursion Pharmaceuticals ROEDENTSPLY SIRONA ROERecursion Pharmaceuticals operating marginDENTSPLY SIRONA operating marginRecursion Pharmaceuticals revenue growthDENTSPLY SIRONA revenue growthRecursion Pharmaceuticals free cash flowDENTSPLY SIRONA free cash flow
Recursion Pharmaceuticals & DENTSPLY SIRONA appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.